Video microscope recording of the dynamic course of thrombosis and thrombolysis of the retinal vein in rabbits
- PMID: 20094009
- DOI: 10.1097/IAE.0b013e3181c71ea6
Video microscope recording of the dynamic course of thrombosis and thrombolysis of the retinal vein in rabbits
Abstract
Purpose: The purpose of this study was to investigate the dynamic course of experimental thrombosis and thrombolysis of the retinal veins.
Methods: Dynamic changes in the blood flow in the retinal veins were documented on a digital recorder through a microscope-mounted video camera and were analyzed on a monitor by video playback. Photochemical thrombus formation was induced by intravenous injection of 30% Rose Bengal followed by endoillumination of individual branch retinal veins of the eyes of 20 anesthetized pigmented rabbits. Subsequently, 10 rabbits were treated with an infusion in an ear vein of 3 mg/kg recombinant tissue plasminogen activator, whereas 10 control rabbits were administered with similar volumes of normal saline solution. Occlusion and recanalization were confirmed histologically and assessed by video microscopy.
Results: At the site exposed to light, photochemical injury resulted in the formation of a white thrombus, stagnation of blood flow, and subsequent complete venous occlusion in 20 rabbits. In this study, of the 10 animals in the recombinant tissue plasminogen activator treatment group, 9 (90%) showed evident thrombolysis, whereas none of the control group animals showed evident thrombolysis. The video showed that the massive thrombus disrupted into nonuniform fragments, which were quickly washed away by the blood flow, and the circulation was reestablished with no recurrence of secondary obstruction.
Conclusion: In vivo data suggest that video microscopy may provide a visual approach for observing the dynamic changes occurring during experimental thrombus formation and lysis by the early administration of recombinant tissue plasminogen activator; this approach may assist in future investigation of thrombus research of ocular fundus.
Similar articles
-
The rationale of retinal endovascular fibrinolysis in the treatment of retinal vein occlusion: from experimental data to clinical application.Retina. 2012 Sep;32(8):1566-73. doi: 10.1097/IAE.0b013e318241ae55. Retina. 2012. PMID: 22466460
-
Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.Am J Ophthalmol. 2004 Nov;138(5):829-39. doi: 10.1016/j.ajo.2004.06.083. Am J Ophthalmol. 2004. PMID: 15531319
-
Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.Retina. 2009 Jul-Aug;29(7):932-40. doi: 10.1097/IAE.0b013e3181a3b870. Retina. 2009. PMID: 19584651 Clinical Trial.
-
Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.Thromb Haemost. 1996 Oct;76(4):615-20. Thromb Haemost. 1996. PMID: 8903005
-
The response of the vessel wall to thrombosis: the in vivo study of venous thrombolysis.Ann N Y Acad Sci. 1992 Dec 4;667:127-40. doi: 10.1111/j.1749-6632.1992.tb51605.x. Ann N Y Acad Sci. 1992. PMID: 1309031 Review.
Cited by
-
Investigation into safflower injection as a prophylactic treatment for retinal vein occlusion in a rabbit model.Sci Rep. 2024 Apr 5;14(1):8048. doi: 10.1038/s41598-024-58734-z. Sci Rep. 2024. PMID: 38580804 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources